SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Vice-Premier He Lifeng on Tuesday told Sanofi chairman Frédéric Oudéa that China will continue to improve its operating environment for businesses and welcome European firms in the country ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

The site, which will be in the Beijing Economic and Technological Development Zone, will be Sanofi’s fourth production and supply base in China, Sanofi said in its official WeChat account.

Chinese authorities rolled out the red carpet for French pharmaceutical and healthcare giant Sanofi, which plans to invest ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...